High levels of FGF-23 in patients with type 2 diabetes are associated with a number of structural disorders, the most important and significant of which is the development of cardiac hypertrophy.
Original language
Russian
Pages (from-to)
34-39
Journal
Лечебное дело: научно-практический терапевтический журнал
